Razvan T. Radulescu
About
In The Last Decade
Razvan T. Radulescu
18 papers receiving 260 citations
Peers
Comparison fields: 5 of 41
- Molecular Biology 198
- Endocrinology, Diabetes and Metabolism 167
- Cancer Research 107
- Oncology 78
- Genetics 38
Countries citing papers authored by Razvan T. Radulescu
This map shows the geographic impact of Razvan T. Radulescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Razvan T. Radulescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Razvan T. Radulescu more than expected).
Fields of papers citing papers by Razvan T. Radulescu
This network shows the impact of papers produced by Razvan T. Radulescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Razvan T. Radulescu. The network helps show where Razvan T. Radulescu may publish in the future.
Co-authorship network of co-authors of Razvan T. Radulescu
This figure shows the co-authorship network connecting the top 25 collaborators of Razvan T. Radulescu. A scholar is included among the top collaborators of Razvan T. Radulescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Razvan T. Radulescu. Razvan T. Radulescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The nucleocrine pathway comes of age. | 2 |
| 2 | 1 | |
| 3 | The practical utility of synthetic tumor suppressor peptides: a personal retrospective on 25 years. | 1 |
| 4 | Oncoprotein metastasis: an expanded topography. | 4 |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 12 | |
| 8 | 7 | |
| 9 | Targeting the RB pathway for cancer therapy: peptide mimetic foundations and promise. | 4 |
| 10 | 17 | |
| 11 | 2 | |
| 12 | 10 | |
| 13 | 8 | |
| 14 | 2 | |
| 15 | 2 | |
| 16 | 121 | |
| 17 | 70 | |
| 18 | 17 | |
| 19 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.